RELMADA THERAPEUTICS, INC. — Director's Dealing 2019

Jul 30, 2019

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: RELMADA THERAPEUTICS, INC. (RLMD)
CIK: 0001553643
Period of Report: 2019-07-29

Reporting Person: Ence Chuck (Chief Financial Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Options to purchase common stock	$2.20	2029-07-29	Common Stock (100000)		Direct

Footnotes

F1: The options vest on January 31, 2020, so long as Mr. Ence is a consultant of the company at such time and the company's common stock is approved for listing on the Nasdaq Stock Market LLC. If the company terminates Mr. Ence before January 31, 2020 without cause, the options shall vest immediately.